|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.290 USD | +1.31% |
|
-1.90% | -11.52% |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides | |
| 06-01 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Transcripts
- Stock Market
- Stocks
- IMTX Stock
- News Immatics N.V.
- Transcripts
Select your edition
All financial news and data tailored to specific country editions
















